The Effect of a Structured Exercise Program on Fatigue, Strength, Endurance,
Physical Self-Efficacy, and Functional Wellness in Women with Early Stage
Breast Cancer
by
SA Crowley PhD, RN, AOCN, BL Metzger PhD, RN, FAAN, SD Merajver PhD, MD, E Chottiner
MD, JC Krauss MD, M Rubenfire MD, AC Eisenberg MD, DF Hayes MD, A Schott MD,
MS Wicha MD. (1998 Rho Chapter Research Grant)
Cancer treatment-related fatigue is a distressing effect of cancer therapy.
Early efforts on describing the fatigue experience have progressed to testing
potential interventions. This study built on the fatigue, functional capacity,
and exercise activity of previous studies (MacVicar et al 1989, Mock et al
1994, 1997, 2001, and Schwartz 2000). Strength training and the nature of the
relationship of physical self-efficacy and performance to functional wellness
contribute new understanding to this area of fatigue and symptom management.
The purpose of this pilot study was to test the effectiveness of a structured
exercise program in decreasing fatigue, increasing strength and endurance,
increasing physical self-efficacy, and enhancing perceptions of functional
wellness in women undergoing adjuvant chemotherapy (Adriamycin and Cytoxan)
for early stage breast cancer. Specific aims of this study in women undergoing
adjuvant therapy for newly diagnosed breast cancer were: 1) to determine the
effects of a structured exercise program on fatigue, performance (endurance
and strength), and physical self-efficacy; 2) to determine the effects of a
structured exercise program on functional wellness; and 3) to determine the
feasibility of conducting an exercise study with this population.
A conceptual model was proposed, identifying relationships among the focal
concepts of cancer treatment-related fatigue, performance, physical self-efficacy,
and functional wellness. The structured exercise program was the predictor
variable. A randomized two-group repeated measures experimental design was
used. A sample of 26 women (36-58 years) with newly diagnosed Stage I or II
breast cancer, were randomized to comparison (n=11) and intervention (n=15)
groups. Both groups were tested at weeks 1 and 13 for endurance (VO2max) and
strength (1-Repetition Maximum). Measurement of fatigue (Revised Piper Fatigue
Scale, Attention Functional Index), physical self-efficacy (Physical Self-Efficacy
Subscale), and functional wellness (MOS SF-36, Functional Wellness Questionnaire)
occurred at weeks 1, 7, and 13.
The study intervention consisted of a 13-week, home-based, structured endurance
and strength-training exercise program. The endurance intervention consisted
of a walking prescription for frequency, duration, and intensity targets per
week. The strength intervention consisted of performance of weekly targets
for frequency and repetitions with progressive resistance training using exercise
tubing. The comparison group continued their current exercise program over
the 13-week period. Exercise diaries were maintained by all study participants
over the study period.
Data analysis found significant differences between the groups in VO2max,
exercise activity, and perceptions of fatigue and functional wellness over
the 13 week period.
The intervention group reported significantly higher minutes and days per
week of exercise activity than the comparison group. The comparison group had
a 4.38 mean decline (16.94%) in VO2max as compared to a 0.459 mean improvement
(1.96%) in VO2max in the intervention group. A significant difference in the
total fatigue score was found between the two groups at week 13, with the intervention
group reporting lower levels of fatigue than the comparison group. Perceptions
of functional wellness were significant at week 7 between the two groups, with
the intervention group having a more positive perception of their state of
wellness at the midpoint of their treatment regimen. Significant correlations
were found between fatigue, vitality, attentional fatigue, and physical self-efficacy.
The SF-36 physical functioning subscale significantly correlated to physical
self-efficacy.
Preliminary testing of the conceptual model proposed in this study was performed
via stepwise multiple regression. Support was found for several of the proposed
relationships with this sample population. Exercise dose was calculated for
all study participants to differentiate the impact of exercise alone from the
effect of an exercise program. Dose regressed on VO2max explained 21.5% of
the variability of the change in VO2max over time. As the dose of activity
increased, the negative change in VO2max decreased. When participation in a
structured exercise program was regressed on VO2max change over time, almost
37% of the variance could be explained by group assignment (comparison versus
intervention group). It was postulated that as fatigue increased over time,
perceptions of physical self-efficacy would decrease. Cancer treatment-related
fatigue explained 51% of the change from time 2 to time 3 in physical self-efficacy.
The results of this pilot study suggest that:
- being a participant in a structured exercise program does make a difference
in perceptions of fatigue, physical self-efficacy, physical performance,
and functional wellness;
- the midpoint of treatment (week 7), may be the time
where the strongest negative effects of treatment are perceived by patients;
- a structured exercise program may provide a means to enhance perceptions
of empowerment, confidence, and focus across the treatment period;
- exercise
appears to have a role in lessening the overall perception of fatigue,
specifically that fatigue that interferes with the ability to work
and socialize; and
- middle-aged women undergoing a specific type of adjuvant chemotherapy
for early stage breast cancer, may engage in structured exercise across
a treatment period.
Results from this preliminary work, will be further tested and explored with
additional sample populations of women undergoing treatment for early stage
breast cancer.

SIGMA THETA TAU RHO CHAPTER
Questions/Comments
University of Michigan School of Nursing 400 North Ingalls Ann Arbor MI 48109-0482